OTC Pharmaceuticals - Poland

  • Poland
  • In Poland, the revenue generated in the OTC Pharmaceuticals market is expected to reach US$4,643.00m in 2024.
  • It is projected to grow annually by 7.59% (CAGR 2024-2029).
  • Among the various markets, the largest is Cold & Cough Remedies, with a market volume of US$1,182.00m in 2024.
  • When compared globally, the in the United States generates the highest revenue, amounting to US$41,240.00m in 2024.
  • In terms of per person revenues, in Poland generates US$115.40 per person in 2024.
  • Furthermore, online sales are expected to contribute 15.93% of the total revenue in the OTC Pharmaceuticals market by 2024.
  • Poland's OTC Pharmaceuticals market is witnessing a surge in demand for natural and herbal remedies, driven by growing consumer preference for traditional medicine.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Poland has been experiencing steady growth in recent years, driven by changing customer preferences, emerging trends in the market, and local special circumstances. Customer preferences in Poland have shifted towards self-medication and a preference for over-the-counter (OTC) medications. This is partly due to the convenience and accessibility of OTC products, as well as the increasing awareness and knowledge among consumers about self-care and managing minor ailments. Additionally, the rising healthcare costs and long waiting times for doctor appointments have also contributed to the growing demand for OTC medications in Poland.One of the key trends in the OTC Pharmaceuticals market in Poland is the increasing popularity of natural and herbal remedies. Consumers are becoming more conscious of their health and are seeking alternative treatments that are perceived as safer and more natural. As a result, there has been a growing demand for OTC products that are made from natural ingredients and have fewer side effects. This trend is also in line with the global shift towards natural and organic products.Another trend in the market is the growing demand for OTC medications for specific conditions, such as allergies, digestive disorders, and sleep disorders. This can be attributed to the increasing prevalence of these conditions in Poland, as well as the changing lifestyle and dietary habits of the population. As a result, pharmaceutical companies are expanding their product portfolios to cater to these specific needs and preferences.Local special circumstances in Poland, such as the aging population and the increasing burden on the healthcare system, have also contributed to the growth of the OTC Pharmaceuticals market. The aging population in Poland has led to an increase in the prevalence of chronic diseases and a higher demand for medications to manage these conditions. Additionally, the limited availability of healthcare professionals and the long waiting times for appointments have further fueled the demand for OTC medications as a convenient and cost-effective solution.Underlying macroeconomic factors, such as the stable economic growth and increasing disposable income in Poland, have also played a role in the development of the OTC Pharmaceuticals market. As the economy grows, consumers have more purchasing power and are willing to spend on healthcare products and services. This has created a favorable market environment for pharmaceutical companies to invest in research and development, expand their product offerings, and engage in marketing activities to promote OTC medications.In conclusion, the OTC Pharmaceuticals market in Poland is developing due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication, the growing demand for natural and herbal remedies, and the increasing prevalence of specific conditions are driving the growth of the market. Additionally, the aging population, limited availability of healthcare professionals, and stable economic growth are also contributing to the development of the OTC Pharmaceuticals market in Poland.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)